Skip to main content
Caplight Logo









Orthosnap

Orthosnap

Private
Westbury, New YorkHealthcare & Life Scienceshttps://orthosnap.com

Last Round

Series A

Jul 18, 2019

Est. Valuation

$20M

Company Overview

Orthosnap operates in Healthcare & Life Sciences and is based in Westbury, New York. Its latest recorded funding round was a Series A round in July 2019.

Orthosnap is a medical device company that manufactures and distributes clear dental aligners using a patented dynamic physical model system to provide precise tooth movement for orthodontic patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Orthosnap Comparables

Compare Orthosnap with similar companies based on industry and business-model similarity.

Orthosnap comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Six Month Smiles
81%
OrthoFX
81%
Candid
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Orthosnap Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 18, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Michael Yoon

President & CEO

Executive Team

For institutional investors. Book with your work email.

Orthosnap Investors

Notable investors and investment history

Orthosnap investors
InvestorRounds
Loeb.nycSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2019

    Raised $20M post-money round led by Loeb.nyc.

Book a demo to see all signals

For institutional investors. Book with your work email.

Orthosnap Filings

Explore SEC and related filing metadata, where available.

Orthosnap filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Orthosnap's valuation, stock price, and market status.

Is Orthosnap a public or private company?

Orthosnap is a private company.

What is the current stock price of Orthosnap?

Orthosnap is a private company, so its shares have no public market price. Caplight tracks Orthosnap's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Orthosnap worth (valuation)?

Orthosnap's valuation is estimated at $20.0M based on funding round data.

Can I buy Orthosnap stock?

Orthosnap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Orthosnap's last funding round?

Orthosnap's most recent funding round was Series A on July 18, 2019.

Who are the main investors in Orthosnap?

Key investors in Orthosnap include Loeb.nyc.

Will Orthosnap IPO soon?

No public IPO plans have been announced for Orthosnap.

How can I track Orthosnap secondary market activity?

Caplight tracks bids, offers, and trades in Orthosnap's shares on secondary markets.

Firmographic Details

HeadquartersWestbury, New York
Employee Range12
Year Founded2010
Last FundingJul 18, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?